Keymed Biosciences Inc.
2162Biotechnology
HK$66.90−0.37%As of Oct 29vs prior close
- Market cap
- $2.5B
- P/E (FY1)
- 18.6×
- From 52W high
- −22.75%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥834.6M
- Net margin
- 92.69%
Nomior Score
46
Steady ProfileBottom 41% of the scored universe
Growth59
Quality54
Value38
Momentum—
Resilience40
Growth
+92.73%revenue a year over 3 fiscal years
YE22 CN¥100.1MLTM CN¥834.6M
Connections
Revenue to profitYE25
The net loss was 73% of revenue, narrower by 47 pts on a year.